A detailed history of Souders Financial Advisors transactions in Amgen Inc stock. As of the latest transaction made, Souders Financial Advisors holds 2,708 shares of AMGN stock, worth $841,863. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,708
Holding current value
$841,863
% of portfolio
0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $728,099 - $878,908
2,708 New
2,708 $769,000
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $669,912 - $851,204
2,925 New
2,925 $768,000
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $426,984 - $473,707
-1,828 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $69,014 - $80,424
311 Added 20.5%
1,828 $455,000
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $7,573 - $9,018
35 Added 2.36%
1,517 $349,000
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $347,751 - $386,727
1,482 New
1,482 $358,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Souders Financial Advisors Portfolio

Follow Souders Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Souders Financial Advisors with notifications on news.